Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Dow
Federal Trade Commission
Harvard Business School
AstraZeneca
Johnson and Johnson
QuintilesIMS
Fuji

Generated: December 10, 2018

DrugPatentWatch Database Preview

Goserelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for goserelin acetate and what is the scope of goserelin acetate freedom to operate?

Goserelin acetate is the generic ingredient in one branded drug marketed by Tersera Theraps Llc and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Goserelin acetate has fifty patent family members in thirty-three countries.

There are five drug master file entries for goserelin acetate. Two suppliers are listed for this compound.

Summary for goserelin acetate
Pharmacology for goserelin acetate
Medical Subject Heading (MeSH) Categories for goserelin acetate
Synonyms for goserelin acetate
(D-Ser(tBu)6,Azagly10)-LHRH (free base)
(D-Ser(tBu)6,Azagly10)-LHRH acetate
[D-Ser(tBu)6,Azagly10]-LHRH acetate salt
0F65R8P09N
1-(5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-prolyl)semicarbazide
1-9-Luteinizing hormone-releasing factor (swine), 6-(O-(1,1-dimethylethyl)-D-serine)-, 2-(aminocarbonyl)hydrazide, acetate (salt)
145781-92-6
4-D-Ser-goserelin
6-[O-(1,1-Dimethylethyl)-D-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(Aminocarbonyl)hydrazide Acetate
6-[O-(1,1-Dimethylethyl)-D-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(Aminocarbonyl)hydrazide Acetate Deuterated
65807-02-5
6YUU2PV0U8
70280-59-0
781G926
807G025
81G926
AB01275466-01
AC1NSK1T
AKOS015994653
AKOS030213245
AstraZeneca (TN)
B3723
CAS-145781-92-6
CG-048
CHEBI:5523
CHEMBL1200501
CHEMBL1201247
CS-3114
CS-4509
D-Ser(But)6Azgly10-gonadorelin
D-Ser(But)6Azgly10-gonadorelin Deuterated
D-Ser(But)6Azgly10LHRH
D-Ser(t-Bu)(sup 6)aza-gly(sup 10)-GNRH
D00573
D00BCG
D04405
DB00014
Decapeptide I
DSSTox_CID_26736
DSSTox_GSID_46736
DSSTox_RID_81865
DTXSID7048297
DTXSID9046736
Fertilan
Fertilan Deuterated
goserelin
Goserelin (acetate)
Goserelin (USAN/INN)
Goserelin [USAN:INN:BAN]
Goserelin acetate (JAN/USP)
Goserelin acetate [JAN]
Goserelin acetate, >=99% (HPLC), white powder
Goserelin acetate, United States Pharmacopeia (USP) Reference Standard
Goserelin Deuterated Acetate
Goserelin for NMR identification, European Pharmacopoeia (EP) Reference Standard
Goserelin, European Pharmacopoeia (EP) Reference Standard
Goserelina
Goserelina [Spanish]
Gosereline
Gosereline [French]
Goserelinum
Goserelinum [Latin]
GTPL3879
HMS2089D16
HS-2015
HSDB 7606
HY-13673
HY-13673A
ICI 118,630
ICI 118630
ICI-118630
IKDXDQDKCZPQSZ-JHYYTBFNSA-N
KS-00002WUS
Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide
MFCD00867894
MFCD01747329
MolPort-006-823-831
MolPort-046-033-629
NCGC00167588-02
NCGC00183275-01
SCHEMBL19712239
SCHEMBL6094
SCHEMBL8643
Tox21_112579
Tox21_112937
UNII-0F65R8P09N
UNII-6YUU2PV0U8
ZD-9393
Zoladex
Zoladex (TN)

US Patents and Regulatory Information for goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Sign Up ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Sign Up ➤ Sign Up
Tersera Theraps Llc ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
US Department of Justice
AstraZeneca
Argus Health
Johnson and Johnson
Merck
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.